Antiviral Suppression vs Restoration of RIG-I Signaling by Hepatitis C Protease and Polymerase Inhibitors
- 30 November 2008
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 135 (5) , 1710-1718.e2
- https://doi.org/10.1053/j.gastro.2008.07.023
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursorProceedings of the National Academy of Sciences, 2007
- GB Virus B Disrupts RIG-I Signaling by NS3/4A-Mediated Cleavage of the Adaptor Protein MAVSJournal of Virology, 2007
- Hepatitis C Virus Core Protein Blocks Interferon Signaling by Interaction with the STAT1 SH2 DomainJournal of Virology, 2006
- The Specific and Essential Role of MAVS in Antiviral Innate Immune ResponsesImmunity, 2006
- Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infectionProceedings of the National Academy of Sciences, 2006
- Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virusNature, 2005
- Evasion of intracellular host defence by hepatitis C virusNature, 2005
- Production of infectious hepatitis C virus in tissue culture from a cloned viral genomeNature Medicine, 2005
- HCV NS3 Serine Protease-neutralizing Single-chain Antibodies Isolated by a Novel Genetic ScreenJournal of Molecular Biology, 2005
- A double whammy for hep CNature Reviews Drug Discovery, 2003